Buzzworthy developments of the past few days.

AI transparency in medical devices is achievable and imperative, according to new guidance jointly promoted by the FDA, Health Canada and the U.K.’s Medicines and Healthcare products Regulatory Agency.

The past five years have been boom times for AI startups courting venture investors in healthcare, and the good times just keep rolling.

The Improving Seniors’ Timely Access to Care Act has been considered by Congress multiple times, getting closer than ever in 2023. Will 2024 be the year it finally lands on the president's desk?

As profit margins in healthcare continue to shrink, telemedicine and remote monitoring are seeing a large increase to help cut costs while still delivering care outside of the hospital.

Medical professionals using AI in clinical decision-making should limit the technology’s reach to a supportive role, says the ACP.

Healthcare's ongoing shift toward value-based care is a good thing, Joynt Maddox explained, but its implementation has been far from ideal. She also discussed population health, the pandemic, health disparities and the rising influence of private equity investments.

While one of the new devices was developed for the general public, the second was specifically designed for users with type 2 diabetes who do not take insulin.